4.7 Review

A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Meeting Abstract Clinical Neurology

Patients with major depressive disorder have lower cerebral serotonin 4 receptor binding than healthy controls

K. Koehler-Forsberg et al.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)

Article Clinical Neurology

Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression

C. N. Haile et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)

Article Neurosciences

Inhibition of Glycine Transporter-I as a Novel Mechanism for the Treatment of Depression

Chih-Chia Huang et al.

BIOLOGICAL PSYCHIATRY (2013)

Article Clinical Neurology

A randomized add-on trial of high-dose D-cycloserine for treatment-resistant depression

Uriel Heresco-Levy et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)

Article Clinical Neurology

Serial infusions of low-dose ketamine for major depression

Keith G. Rasmussen et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2013)

Review Neurosciences

Ketamine for Depression: Where Do We Go from Here?

Marije Aan Het Rot et al.

BIOLOGICAL PSYCHIATRY (2012)

Article Pharmacology & Pharmacy

Ketamine as a Novel Antidepressant: From Synapse to Behavior

J. W. Murrough

CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)

Article Clinical Neurology

Ketamine for Treatment-Resistant Unipolar Depression Current Evidence

Sanjay J. Mathew et al.

CNS DRUGS (2012)

Article Medicine, General & Internal

Interpretation of random effects meta-analyses

Richard D. Riley et al.

BMJ-BRITISH MEDICAL JOURNAL (2011)

Article Medicine, General & Internal

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Julian P. T. Higgins et al.

BMJ-BRITISH MEDICAL JOURNAL (2011)

Article Psychiatry

A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression

Nancy Diazgranados et al.

ARCHIVES OF GENERAL PSYCHIATRY (2010)

Article Neurosciences

Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression

Marije aan het Rot et al.

BIOLOGICAL PSYCHIATRY (2010)

Review Pharmacology & Pharmacy

Glutamate-based antidepressants: 20 years on

Phil Skolnick et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2009)

Review Biotechnology & Applied Microbiology

Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders

Gerard Sanacora et al.

NATURE REVIEWS DRUG DISCOVERY (2008)

Article Psychiatry

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

Carlos A. Zarate et al.

ARCHIVES OF GENERAL PSYCHIATRY (2006)

Article Clinical Neurology

Functional impairment in the remission phase of bipolar disorder

A Fagiolini et al.

BIPOLAR DISORDERS (2005)

Article Psychiatry

An open-label trial of riluzole in patients with treatment-resistant major depression

CA Zarate et al.

AMERICAN JOURNAL OF PSYCHIATRY (2004)

Article Medicine, General & Internal

Post-randomisation exclusions:: the intention to treat principle and excluding patients from analysis

D Fergusson et al.

BMJ-BRITISH MEDICAL JOURNAL (2002)

Article Anesthesiology

Small-dose ketamine improves the postoperative state of depressed patients

A Kudoh et al.

ANESTHESIA AND ANALGESIA (2002)

Article Mathematical & Computational Biology

Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes

JJ Deeks

STATISTICS IN MEDICINE (2002)

Article Neurosciences

Antidepressant effects of ketamine in depressed patients

RM Berman et al.

BIOLOGICAL PSYCHIATRY (2000)